文献速递眼底病与葡萄膜炎

Malattia Leventinese/Doyne蜂窝状视网膜营养不良的临床替代终点:两年自然史研究

Clinical Surrogate Endpoints in Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy: Findings From a Two-Year Natural History Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

这项多中心队列研究纳入25例基因确诊的Malattia Leventinese患者,采用多模态影像和微视野检查随访2年。结果显示RPEDC厚度每年增加2.24 µm,感光细胞内节和外核层厚度分别每年减少0.70 µm和1.95 µm,暗视敏感度每年下降约0.40 dB而明视敏感度稳定。研究支持外核层和感光细胞内节厚度作为结构终点、暗视敏感度作为早期功能终点。

要点

  • RPEDC增厚抵消外层视网膜变薄,总视网膜厚度保持稳定。
  • 暗视敏感度随病程显著下降,明视敏感度保持稳定。
  • 外核层和感光细胞内节厚度可作为关键结构终点。

核心结论

  • 在Malattia Leventinese中,总视网膜厚度不变是因为RPEDC增厚抵消了外层视网膜变薄。
  • 仅暗视功能随疾病进展显著下降,且下降主要发生在55岁之前。
  • 外核层和感光细胞内节厚度可作为关键结构终点,暗视敏感度可作为早期功能终点。

研究设计与样本

  • 多中心队列研究,纳入25例基因确诊的Malattia Leventinese患者(15女10男,中位年龄60岁,IQR 51-73岁)。
  • 参与者接受SD-OCT、超广角眼底照相、眼底自发荧光及明视和双色暗视微视野检查。
  • 使用线性混合效应模型评估2年内视网膜层厚度和敏感度变化,并用分段模型估计结构-功能断点。

主要发现

  • RPEDC厚度每年增加2.24 µm。
  • 感光细胞內节厚度每年减少0.70 µm,外核层厚度每年减少1.95 µm,脉络膜厚度每年减少10.83 µm。
  • 总视网膜厚度保持稳定。
  • 暗视敏感度每年下降0.40 dB(505 nm)和0.37 dB(627 nm),明视敏感度保持稳定。
  • 功能下降在疾病早期(玻璃膜疣开始积累时)最为明显。

关键数值与推荐

  • RPEDC厚度变化+2.24 µm/y。
  • 感光细胞內节厚度变化-0.70 µm/y,外核层厚度变化-1.95 µm/y。
  • 脉络膜厚度变化-10.83 µm/y。
  • 暗视敏感度变化-0.40 dB/y(505 nm)和-0.37 dB/y(627 nm)。

临床怎么用

  • 在临床试验中可采用外核层和感光细胞内节厚度作为结构替代终点。
  • 暗视敏感度可用于监测早期疾病进展,尤其55岁以下患者。
  • 明视敏感度可能适用于追踪疾病较晚阶段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy is a rare, inherited retinal dystrophy characterized by drusen formation and early vision loss. Its phenotypical similarities with dry age-related macular degeneration (AMD) make Malattia Leventinese a valuable monogenetic disease model for AMD. Identifying sensitive outcome measures is crucial for clinical trials. This study quantifies retinal pigment epithelium and drusen complex (RPEDC) increase and retinal layer degeneration using fully automated segmentation for multimodal imaging analysis, and investigates structural thresholds associated with functional decline through pointwise correlation. METHODS: This multicenter cohort study included 25 patients (15 women and 10 men; median age = 60 years, interquartile range [IQR] = 51-73 years) with genetically confirmed Malattia Leventinese. Participants underwent multimodal imaging, including spectral-domain optical coherence tomography (SD-OCT), ultrawide fundus retinography and fundus autofluorescence (FAF), and mesopic and two-color scotopic microperimetry. Changes in retinal layer thicknesses and retinal sensitivity were assessed over 2 years using linear mixed-effects models, and structure-function breakpoints were estimated with piecewise models. RESULTS: RPEDC thickness increased (+2.24 µm/y), whereas photoreceptor inner segments (-0.70 µm/y) and outer nuclear layer (-1.95 µm/y) thicknesses, in addition to choroidal thickness (-10.83 µm/y), decreased with disease progression. Total retinal thickness remained stable. Scotopic sensitivity declined over time, with -0.40 decibel (dB)/year at 505 nm and -0.37 dB/year at 627 nm, whereas mesopic sensitivity remained stable. Function decreased most in early disease stages, with the onset of drusen accumulation. CONCLUSIONS: In Malattia Leventinese, the total retinal thickness remains unchanged because the RPEDC increase offsets the thinning of outer retinal layers. Only scotopic function decreases significantly with progression and before the age of 55 years. Mesopic function may serve to track later stages. These findings support the outer nuclear layer and photoreceptor inner segment thicknesses as key structural endpoints and scotopic sensitivity as an early functional outcome measure for monitoring disease progression in ongoing and future clinical trials.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Ehrenzeller C, Cancian G, Kostin V, et al. Clinical Surrogate Endpoints in Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy: Findings From a Two-Year Natural History Study. Invest Ophthalmol Vis Sci. 2026. PMID: 42734305. doi:10.1167/iovs.67.11.24

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。